CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

Show other versions (1)

<h4>Background</h4> COVID-19 has so far affected more than 250 million individuals worldwide, causing more than 5 million deaths. Several risk factors for severe disease have been identified, most of which coincide with advanced age. In younger individuals, severe COVID-19 often occurs i...

Full description

Bibliographic Details
Main Authors: Simone Weber, Victoria Kehl, Johanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Teresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Andreas Moosmann, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H. Busch
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132318/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132318/?tool=EBI

Similar Items